MarketPulse — Real-Time Financial News & Market Analysis

Victoria's Secret stock rallies 93% on strong operational turnaround, improved margins, and institutional investment backing management's execution on strategic initiatives.

Transocean secures $610M in new offshore drilling contracts, expanding total backlog to $6.1B across Brazil, Norway, and Australia operations.

Seldon Capital exits majority stake in ACM Research after selling 183,242 shares for $6.83M. Move comes as semiconductor equipment maker's stock surges 170.7% over past year.

Palo Alto Networks delivered 155% returns over five years amid surging cybersecurity demand. AI-powered solutions and subscription models drove 15% revenue growth and strong shareholder value.

Seldon Capital invests $12.6M in Argentine energy company Pampa Energía, acquiring 4.36% stake. Move reflects confidence in long-term value despite recent underperformance.

Law firm Halper Sadeh launches investigations into four merger deals involving RAPT Therapeutics, Contigo Software, TBNK Therapeutics, and Fold Health to ensure fair shareholder treatment.

NuScale Power faces class action lawsuit alleging misrepresentations about partner ENTRA1's nuclear experience. Shareholders claim undisclosed experience deficiencies pose risks to company's commercialization strategy.

Agilon Health faces securities lawsuit over allegedly false 2025 guidance. Stock fell 51.6% after CEO termination and guidance suspension on August 4.

Class action lawsuit alleges uniQure withheld FDA study design concerns from investors, causing 49% stock decline after disclosure in November 2025.

Relay Therapeutics reports 2025 results February 26, highlighting progress on lead drug zovegalisib advancing through Phase 3 trials with FDA Breakthrough Therapy Designation.

Class action lawsuits filed against Paysafe and Oracle for material omissions in financial disclosures. Paysafe failed to disclose high-risk clients; Oracle misrepresented AI infrastructure costs.

Mereo BioPharma faces securities litigation alleging it misled investors about Phase 3 clinical trial results for setrusumab, failing to disclose the trials missed primary endpoints.

Castle Biosciences' AdvanceAD-Tx test predicts which atopic dermatitis patients will respond to JAK inhibitors, showing 5.5x better outcomes for identified responders versus alternative treatments.

Targa Resources posts record 2025 results and projects continued growth for 2026, solidifying its position as a leading North American midstream infrastructure provider.

Amcor offers 5.3% dividend yield post-merger, but investors should evaluate if current valuations justify entry despite strong fundamentals and recent stock appreciation.

DuPont's board approved a $0.20 per share quarterly dividend payable March 16, 2026, to shareholders of record as of March 2.

Centerra Gold declares C$0.07 quarterly dividend per share, totaling C$14 million, payable March 26, 2026 to eligible shareholders.

Copart shares fell 11% after missing Q2 earnings and revenue targets, reporting $0.36 EPS versus $0.40 expected and $1.12B revenue versus $1.14B anticipated.

Univest Securities completed a $3M direct offering for Chinese EdTech firm JIADE, placing 12 million shares at $0.25 each to fund operations and growth.

Law firm investigates four M&A deals for RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore ahead of March 2026 shareholder votes.